ResearcherGeneral Hospital of Shenyang Military RegionNo recent work listed

Xiaoshu Li

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper

Papers 1

Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. Co-author DOI 10.1186/1475-2867-13-26 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua Wang · 1 shared paper, 2013 · strength 0.04
- Paper Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. DOI 10.1186/1475-2867-13-26 ↗
Fengjun Xiao · 1 shared paper, 2013 · strength 0.04
- Paper Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. DOI 10.1186/1475-2867-13-26 ↗
Lisheng Wang · 1 shared paper, 2013 · strength 0.04
- Paper Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. DOI 10.1186/1475-2867-13-26 ↗
Xiaozhong Guo · 1 shared paper, 2013 · strength 0.04
- Paper Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. DOI 10.1186/1475-2867-13-26 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.